4-(9,10-dihydro-1,8-dihydroxy-9,10-dioxo-2-anthracene)-butanoic acid | 69960-37-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 蒽
• 英文名称: 4-(9,10-dihydro-1,8-dihydroxy-9,10-dioxo-2-anthracene)-butanoic acid
• 英文别名: 4-(1,8-Dihydroxy-9,10-dioxoanthracen-2-yl)butanoic acid
• CAS: 69960-37-8
• 化学式: C₁₈H₁₄O₆
• 分子量: 326.306
• InChiKey: XWFCZTSFIXPQTE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  112
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  4-(9,10-dihydro-1,8-dihydroxy-9,10-dioxo-2-anthracene)-butanoic acid 在 盐酸 、 硫酸 、 盐酸羟胺 、 sodium methylate 、 tin(ll) chloride 作用下， 以 甲醇 、 溶剂黄146 为溶剂， 反应 36.0h， 生成 N-hydroxy-4-(9,10-dihydro-1,8-dihydroxy-9-oxo-2-anthracene)butanamide
  参考文献：
  名称：

  Antipsoriatic Anthrones with Modulated Redox Properties. 4. Synthesis and Biological Activity of Novel 9,10-Dihydro-1,8-dihydroxy-9-oxo-2- anthracenecarboxylic and -hydroxamic Acids

  摘要：

  A novel series of carboxylic and hydroxamic acids based on 1,8-dihydroxy-9(10H)-anthracenone were synthesized from 8-hydroxy-1-methoxy-9,10-anthracenedione as the key intermediate and evaluated both in the bovine polymorphonuclear leukocyte 5-lipoxygenase (5-LO) assay and in the HaCaT keratinocyte proliferation assay for their enzyme inhibitory and antiproliferative activity, respectively. The most potent inhibitors in both assays were the N-methylated hydroxamic acids 5d-8d with straight chain alkyl spacers. Incorporation of these structural features on the anthracenone pharmacophore resulted in increased inhibitory activity against 5-LO while the antiproliferative activity was retained. In addition, prooxidant properties as measured by deoxyribose degradation and cytotoxicity as assessed by LDH release were largely reduced as compared with the antipsoriatic anthralin. Contrary to anthralin, antioxidant properties were observed as documented by the reactivity of the novel compounds against free radicals and inhibition of lipid peroxidation in model membranes.

  DOI：

  10.1021/jm9701785
• 作为产物：
  描述：

  1-羟基-8-甲氧基-9,10-蒽醌 在 sodium hydroxide 、 重铬酸吡啶 、 sodium dithionite 、 air 、 氢溴酸 、 溶剂黄146 、 三(二甲胺基)膦 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 15.0h， 生成 4-(9,10-dihydro-1,8-dihydroxy-9,10-dioxo-2-anthracene)-butanoic acid
  参考文献：
  名称：

  Antipsoriatic Anthrones with Modulated Redox Properties. 4. Synthesis and Biological Activity of Novel 9,10-Dihydro-1,8-dihydroxy-9-oxo-2- anthracenecarboxylic and -hydroxamic Acids

  摘要：

  A novel series of carboxylic and hydroxamic acids based on 1,8-dihydroxy-9(10H)-anthracenone were synthesized from 8-hydroxy-1-methoxy-9,10-anthracenedione as the key intermediate and evaluated both in the bovine polymorphonuclear leukocyte 5-lipoxygenase (5-LO) assay and in the HaCaT keratinocyte proliferation assay for their enzyme inhibitory and antiproliferative activity, respectively. The most potent inhibitors in both assays were the N-methylated hydroxamic acids 5d-8d with straight chain alkyl spacers. Incorporation of these structural features on the anthracenone pharmacophore resulted in increased inhibitory activity against 5-LO while the antiproliferative activity was retained. In addition, prooxidant properties as measured by deoxyribose degradation and cytotoxicity as assessed by LDH release were largely reduced as compared with the antipsoriatic anthralin. Contrary to anthralin, antioxidant properties were observed as documented by the reactivity of the novel compounds against free radicals and inhibition of lipid peroxidation in model membranes.

  DOI：

  10.1021/jm9701785

文献信息

• KROHN K.; HEMME C., LIEBIGS ANN. CHEM., 1979, NO 1, 19-34
  作者：KROHN K.、 HEMME C.

  DOI：——

  日期：——
• US5922891A
  申请人：——

  公开号：US5922891A

  公开（公告）日：1999-07-13
• Antipsoriatic Anthrones with Modulated Redox Properties. 4. Synthesis and Biological Activity of Novel 9,10-Dihydro-1,8-dihydroxy-9-oxo-2- anthracenecarboxylic and -hydroxamic Acids
  作者：Klaus Müller、Helge Prinz

  DOI：10.1021/jm9701785

  日期：1997.8.1

  A novel series of carboxylic and hydroxamic acids based on 1,8-dihydroxy-9(10H)-anthracenone were synthesized from 8-hydroxy-1-methoxy-9,10-anthracenedione as the key intermediate and evaluated both in the bovine polymorphonuclear leukocyte 5-lipoxygenase (5-LO) assay and in the HaCaT keratinocyte proliferation assay for their enzyme inhibitory and antiproliferative activity, respectively. The most potent inhibitors in both assays were the N-methylated hydroxamic acids 5d-8d with straight chain alkyl spacers. Incorporation of these structural features on the anthracenone pharmacophore resulted in increased inhibitory activity against 5-LO while the antiproliferative activity was retained. In addition, prooxidant properties as measured by deoxyribose degradation and cytotoxicity as assessed by LDH release were largely reduced as compared with the antipsoriatic anthralin. Contrary to anthralin, antioxidant properties were observed as documented by the reactivity of the novel compounds against free radicals and inhibition of lipid peroxidation in model membranes.